Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-15T20:57:11.270Z Has data issue: false hasContentIssue false
  • English
  • Français

The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant Enterobacteriaceae from five teaching hospitals in central China

Published online by Cambridge University Press:  20 November 2013

L. HU ,
Q. ZHONG ,
Y. SHANG ,
H. WANG ,
C. NING ,
Y. LI ,
Y. HANG ,
J. XIONG ,
X. WANG  and
Y. XU
...Show all authors
L. HU
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
Q. ZHONG
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
Y. SHANG
Affiliation:
Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
H. WANG
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
C. NING
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
Y. LI
Affiliation:
Department of Respiratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
Y. HANG
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
J. XIONG
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
X. WANG
Affiliation:
Department of Laboratory Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China
Y. XU
Affiliation:
Department of Respiratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
Z. QIN
Affiliation:
Departments of Medicine and Microbiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
C. PARSONS
Affiliation:
Departments of Medicine and Microbiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
L. WANG*
Affiliation:
Department of Respiratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
F. YU*
Affiliation:
Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
*
(Email: 38805@163.com)
*Author for correspondence: Dr F. Yu, Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325 000, China. (Email: wzjxyfy@163.com)
Rights & Permissions [Opens in a new window]

Summary

We investigated the prevalence of β-lactamase genes and plasmid-mediated quinolone resistance (PMQR) determinants in 51 carbapenem-resistant Enterobacteriaceae (CRE) from five teaching hospitals in central China. The prevalence of carbapenem resistance in Enterobacteriaceae was 1·0% (51/5012). Of 51 CRE, 31 (60·8%) isolates were positive for one tested carbapenemase gene, while 10 (19·6%) were simultaneously positive for two tested carbapenemase genes. The positive rates of blaKPC-2, blaNDM-1, blaIMP-4, blaIMP-26 and blaIMP-8 were 54·9%, 17·6%, 11·8%, 11·8% and 3·9%, respectively. Of 10 CRE with two carbapenemase genes, three, five, one and one were positive for blaKPC-2 and blaIMP-4, blaKPC-2 and blaIMP-26, blaKPC-2 and blaIMP-8, and blaKPC-2 and blaNDM-1, respectively. Eight of nine blaNDM-1-positive isolates lacked carbapenemases by the modified Hodge test, while 27/28 isolates harbouring blaKPC-2 were positive for carbapenemases determined by this test; 41·2% of the CRE-positive isolates also harboured ESBL genes in various combinations (three and two positive for blaKPC-2 also carried blaDHA-1 and blaCMY-2). The positive rates of qnrS1, qnrA1, qnrB and aac-(6/)-Ib-cr in CRE were 25·5%, 9·8%, 23·5% and 15·7%, respectively. In particular, 7/9 isolates harbouring blaNDM-1 were positive for these quinolone resistance genes, of which five carried qnrS1 and two carried qnrS1 and qnrB4. All but two of 29 Klebsiella pneumoniae isolates were grouped into 20 clonal clusters by PFGE, with the predominant cluster accounting for four blaKPC-2-positive isolates distributed in the same hospital. We conclude that there is a high prevalence of blaNDM-1 and PMQR determinants in CRE isolates in central China. Multiple resistance determinants in various combinations co-exist in these strains and we report for the first time the co-existence of blaKPC-2 and blaIMP-26 in a strain of Klebsiella oxytoca.

Keywords

CarbapenemasesEnterobacteriaceaequinolone resistance determinants
Type
Original Papers
Information
Epidemiology & Infection , Volume 142 , Issue 9 , September 2014 , pp. 1972 - 1977
Copyright
Copyright © Cambridge University Press 2013 

INTRODUCTION

Multidrug resistance (MDR) in Enterobacteriaceae is a serious threat to public health as it limits the selection of antimicrobials for empirical treatment of infections caused by Gram-negative organisms [Reference Tzouvelekis1]. Carbapenems are effective agents for the treatment of clinical infections caused by MDR Enterobacteriaceae; however, resistance of these organisms to these agents has been increasingly associated with production of carbapenemases, loss of porins, and expression of β-lactamases such as extended-spectrum β-lactamases (ESBLs) or AmpC enzymes [Reference Tzouvelekis1]. Klebsiella pneumoniae carbapenemases (KPCs), especially KPC-2, are widespread in Enterobacteriaceae [Reference Rapp2] and the Ambler class B metallo-β-lactamases (MBLs), including IMP and VIM, are commonly harboured by non-fermentative bacteria and, more recently, in Enterobacteriaceae worldwide [Reference Maltezou3]. More specifically, global dissemination of the emerging New Delhi MBL (NDM), first identified in a clinical urinary tract isolate of K. pneumoniae is becoming a major public health issue [Reference Yong4–Reference Rimrang7] as this determinant has spread and is found in many Gram-negative species in several countries [Reference Yong4–Reference Shahcheraghi9]. In China, NDM-1 was first identified from clonally unrelated Acinetobacter baumannii isolates [Reference Chen10] and subsequently, several reports have identified it in non-baumannii Acinetobacter spp. in China [Reference Fu11–Reference Hu13]. We reported the first NDM-1 isolate of K. pneumoniae from the Chinese mainland [Reference Hu14] and recently, the expression of multiple carbapenemases such as KPC-2 with IMP-4 in K. pneumoniae has been reported [Reference Rimrang7, Reference Dortet15–Reference Wei18] as well as with carbapenemases in other Enterobacteriaceae and Acinetobacter spp. [Reference Rimrang7, Reference Dortet15–Reference Karthikeyan17]. Indeed, carbapenemase genes are able to co-exist with several other resistance genes including ESBL, plasmid-mediated AmpC, plasmid-mediated quinolone resistance (PMQR), and plasmid-mediated aminoglycoside resistance determinants which implies acquisition of MDR by carbapenem-resistant Enterobacteriaceae (CRE) in hospital and community settings [Reference Zhang19, Reference Islam20].

The aim of the present study was to investigate antimicrobial resistance profiles and co-existence of resistance determinants in CRE isolates from five teaching hospitals in central China and to assess the epidemiological relatedness of carbapenem-resistant K. pneumoniae isolates within this cohort. We found a high co-prevalence of β-lactamase genes and PMQR determinants in CRE, and we provide the first documentation of co-existence for bla KPC-2 and bla IMP-26 in a single CRE isolate.

MATERIALS AND METHODS

Isolation and identification of isolates

From January 2011 to September 2012, a total of 5012 isolates of Enterobacteriaceae were recovered from clinical specimens collected from hospitalized patients in five teaching hospitals, including four in Nanchang, central China and one in Jiujiang (170 km north of Nanchang). Fifty-one (1·0%) isolates with resistance to at least one of ertapenem, imipenem and meropenem were defined as CRE. These CRE isolates originated from participants at different locations as follows: the first, second, third and fourth affiliated hospitals of Nanchang University (respectively hospital A, 17 isolates; hospital B, 25 isolates; hospital C, three isolates; hospital D, 4 isolates), and the affiliated hospital of Jiujiang College in Jiujiang (hospital E, two isolates). Identification was performed using a Vitek-32 automated microbiology analyser (bioMérieux, France) according to the manufacturer's instructions, as well as additional standard biochemical testing. Only bacterial isolates comprising >107 c.f.u./ml by semi-quantitative culture from sputum specimens were considered significant and analysed in this study.

Antimicrobial susceptibility

Antimicrobial susceptibilities were determined using Gram-negative susceptibility cards in the Vitek system (bioMérieux) and by disc diffusion in accordance with the guidelines recommended by Clinical and Laboratory Standards Institute (CLSI) [21]. The antimicrobials were ampicillin, piperacillin, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, aztreonam, cefoxitin, imipenem, meropenem, trimethoprim/sulfamethoxazole, amikacin, gentamicin and levofloxacin. Results of susceptibility tests were interpreted according to the criteria recommended by CLSI [21]. Escherichia (Es.) coli ATCC 25 922 was used as quality control strain.

Detection of antimicrobial resistance determinants

The modified Hodge test (MHT) was performed for detection of carbapenemases as described previously [21] and for ESBL production by the the CLSI-recommended confirmatory double-disk combination test [21]. Genes encoding carbapenemases, ESBL genes, plasmid-mediated AmpC and PMQR determinants were detected using polymerase chain reaction (PCR) and nucleotide sequencing employing previously published primers [Reference Poirel22–Reference Yu24].

Pulsed-field gel electrophoresis (PFGE)

Genomic DNA from K. pneumoniae isolates was prepared for PFGE typing and cleaved with 40 U XbaI. Electrophoresis was performed on 1% agarose gels in 0·5 m Tris/borate/EDTA buffer on a CHEF-Mapper XA PFGE system (Bio-Rad, USA) for 24 h at 14°C, with run conditions of 6 V/cm, a pulse angle of 120° and pulse times from 5 s to 20 s. Bands were stained with ethidium bromide (0·5 μg/ml) prior to their identification under UV light. Comparison of the PFGE patterns was performed with Bionumerics software (Applied Maths, Belgium) using the Dice similarity coefficient. Clusters were defined as DNA patterns sharing >85% similarity.

RESULTS AND DISCUSSION

The 51 CRE identified were by species, K. pneumoniae (29), Enterobacter cloacae (8), K. oxytoca (6), Es. coli (4), K. ozaenae (2), Proteus mirabilis (1) and Citrobacter freudii (1). The positive rates of carbapenem resistance in various species of Enterobacteriaceae were as follows: K. pneumoniae, 2·8% (29/1023); E. cloacae, 1·5% (8/523); K. oxytoca, 1·4% (6/427), Es. coli, 0·2% (4/2253), K. ozaenae, 3·4% (2/58), P. mirabilis, 0·8% (1/128) and C. freundii, 1·3% (1/78). These organisms were recovered from sputum (31), urine (5), exudates (4), pus (5), blood (5) and one from a central venous catheter tip. All CRE isolates were resistant to ampicillin and pipercillin. The resistance rates to other antimicrobials were as follows: pipercillin/tazobatam (82·4%), ceftazidime (98·0%), cefotaxime (96·1%), cefepime (94·1%); aztreonam (94·1%), cefoxitin (90·2%), levofloxacin (76·5%), amikacin (43·1%), gentamicin (80·4%) and trimethoprim/sulfamethoxazole (76·5%). All but two of the 51 CRE isolates were resistant to multiple antimicrobials and (84·3%) were susceptible to at least one drug.

A total of 31 (60·8%) CRE isolates expressed carbapenemases based on the MHT and carriage of carbapenemase genes, including bla NDM-1, was investigated further using PCR and DNA sequencing. Most (80·4%) isolates expressed carbapenemase genes and similar to previous reports on Enterobacteriaceae in China [Reference Hu25, Reference Chen26], 54·9% of the isolates in this study harboured bla KPC-2. In China, bla NDM-1 expression has been identified mainly for Actinetobacter spp. [Reference Chen10–Reference Hu13] but the gene has been noted in Enterobacteriaceae in the country, albeit with a relatively low prevalence thus far [Reference Dai27]. We recently reported that two unrelated K. pneumoniae isolates harboured bla NDM-1 [Reference Hu14, Reference Girlich28] and it was unexpected to find such a high prevalence (17·6%) of this gene in CRE in this study. The nine isolates expressing bla NDM-1 included five K. pneumoniae, two K. ozaenae, one K. oxytoca and one Es. coli, indicating that the gene has been disseminated in Enterobacteriaceae in China. This should be a cause for concern for clinicians, microbiologists and administrators for infection control measures. Interestingly, all but one of the bla NDM-1-positive isolates were negative for carbapenemases by the MHT, while 27/28 isolates harbouring bla KPC-2 were positive by this method, indicating that the test is not suitable for the detection of NDM-1 production. The MHT has excellent sensitivity for detection of enterobacterial isolates producing KPC- and OXA-48-type carbapenemases, but has low sensitivity for NDM-1 producers [Reference Girlich28], which is further supported by a previous study which reported negative or weakly positive MHT results for 11/15 NDM-1-producing strains [Reference Castanheira29]; therefore, it is important for clinical laboratories to develop sensitive methods for identifying such strains.

In addition to KPC-2 and NDM-1, IMP-type metallo-β-lactamases also contribute to carbapenem resistance in Enterobacteriaceae. In the present study, 14 CRE isolates expressed bla IMP, including bla IMP-4 (6), bla IMP-26 (6) and bla IMP-8 (2) but all were negative for bla VIM. Co-production of different carbapenamases was also found in clinically important organisms, which poses a challenge for infection control [Reference Rimrang7, Reference Dortet15–Reference Wei18]. We found that 10 isolates simultaneously harboured two carbapenemase genes in various combinations as follows: one isolate each of K. pneumoniae, E. cloacae and K. oxytoca had both bla KPC-2 and bla IMP-4; three K. pneumoniae and two E. cloacae isolates had both bla KPC-2 and bla IMP-26; one C. freudii isolate harboured both bla KPC-2 and bla IMP-8; and a single K. oxytoca isolate harboured both bla KPC-2 and bla NDM-1. Co-existence of bla KPC-2 and bla IMP-4 has previously been documented in K. pneumoniae [Reference Wei18, Reference Wang30], and co-existence of bla KPC-2 and bla IMP-8 was first identified in a K. oxytoca isolate from Shanghai, east China [Reference Li31]. Recently, NDM-1 was also found to co-exist with other carbapenemases, including OXA-23, KPC-2, IMP-26 and OXA-181 [Reference Rimrang7, Reference Dortet15–Reference Karthikeyan17, Reference Dai27]. To the best of our knowledge, the present study is the first to report co-existence of bla KPC-2 and bla IMP-26. in K. pneumoniae and E. cloacae isolates as well as the co-existence of bla KPC-2 and bla NDM-1 in K. oxytoca. The 10 CRE isolates not expressing carbapenemase genes by PCR harboured at least one ESBL gene and/or plasmid-mediated AmpC gene. Carbapenem resistance in these isolates may therefore be associated with other carbapenemases not examined in this study, or other resistance mechanisms including loss of porins and efflux pumps.

Co-production of carbapenemases with other β-lactamases results in resistance to nearly all clinically available β-lactams. Since AmpCs and carbapenemases are not inhibited by clavulanic acid, co-production of ESBLs, AmpCs and carbapenemases can mask identification of ESBLs by the CLSI-recommended double-disk test Detection of multiple β-lactamases produced by Enterobacteriaceae in the clinical laboratory is therefore challenging. In the present study, although ESBL genes were expressed by 62·7% (32/51) of CRE isolates, only 29·4% (15/51) were found to produce ESBLs as determined by the CLSI-recommended double-disk test. Of 32 isolates with ESBL genes, 25 carried bla CTX-M, including bla CTX-M-3 (6), bla CTX-M-14 (5), bla CTX-M-15 (6), both bla CTX-M-9 and bla CTX-M-3 (4), bla CTX-M-65 (2), bla CTX-M-9 (1) and bla CTX-M-84 (1). Thirty (58·8%) CRE isolates harboured bla SHV and comprised 13 isolates with SHV-type ESBL genes, including bla SHV-12 (10), bla SHV-5 (1), bla SHV-28 (1) and bla SHV-36 (1). The remaining 17 bla SHV-positive isolates carried SHV-type narrow spectrum β-lactamase genes, including bla SHV-11 (8) and bla SHV-1 (9). bla TEM was detected in 60·8% (31/51) CRE isolates, and all bla TEM amplicons were identified as the narrow spectrum β-lactamase gene, bla TEM-1. Co-existence of bla SHV- and bla CTX-M-type ESBL genes was identified for six CRE isolates. Twenty-one (41·2%) of the CRE isolates with carbapenemase genes based on PCR also harboured ESBL genes in various combinations, and 21 (41·2%) also expressed AmpCs as determined by the three-dimension test. Thirteen (25·5%) isolates were positive for plasmid-mediated AmpC genes, including bla DHA-1 (6), bla CMY-2 (5), bla MIR-3 (1) and bla ACT-16 (1). Isolates expressing bla KPC-2 simultaneously harboured bla DHA-1 (3) and bla CMY-2 (2). No plasmid-mediated AmpC genes were detected in bla NDM-1-positive isolates.

Although PMQR determinants alone may not confer resistance to quinolones, they do supplement other quinolone resistance mechanisms. In China, PMQR determinants, especially aac-(6/)-Ib-cr, have been found in Enterobacteriaceae clinical isolates [Reference Jiang32]. In the present study, 32 (62·7%) of 51 CRE isolates expressed PMQR determinants, including qnrS1 (11), qnrA1 (4), qnrB2 (2), qnrB4 (6), qnrB10 (1), both qnrS1 and qnrB4 (2), both qnrA1 and qnrB1 (1) and aac-(6/)-Ib-cr (5). Two isolates with qnrS1 and one isolate with qnrB4 were positive for aac-(6/)-Ib-cr. The positive rates for qnrS1, qnrA1, qnrB and aac-(6/)-Ib-cr were 25·5% (13/51), 9·8% (5/51), 23·5% (12/51) and 15·7% (8/51), respectively. Of 41 CRE isolates expressing carbapenemase genes, the prevalence of PMQR determinants was 65·8% (27/41). Specifically, 77·8% (7/9) of isolates harbouring bla NDM-1 expressed PMQR genes, including qnrS1 (5), and both qnrS1 and qnrB4 (2). In a previous study from China, qnr genes were expressed by 67·5% (27/40) of KPC-2-producing K. pneumoniae isolates [Reference Zhang19]. Co-existence of carbapenemase genes and PMQR determinants contributes to MDR.

Of 29 K. pneumoniae CRE isolates, 27 were successfully typed and grouped into 20 clonal clusters by PFGE (Fig. 1), the remaining two isolates were not typable despite repeated attempts. The predominant cluster included four bla KPC-2-positive isolates distributed within the same hospital (the second affiliated hospital of Nanchang University), suggesting dissemination of clonal carbapenemase-producing K. pneumoniae in this facility. Four different clusters with two isolates each were also recovered from patients in this hospital. The remaining 15 profiles were represented by single isolates, and five isolates harbouring bla NDM-1 had unique profiles indicating independent acquisition of these strains and the absence of cross-transmission between patients in the Nanchang area during the study period. In addition, strains of the same DNA profile were not isolated from patients receiving care in different hospitals, which underlined the fact that CRE did not spread between hospitals in the survey.

Fig. 1. Dendrogram of patterns for carbapenem-resistant K. pneumonia isolates obtained by pulsed-field gel electrophoresis.

In conclusion, we report a high prevalence of bla NDM-1 and PMQR determinants in CRE isolates from central China, as well as the co-existence in isolates of multiple resistance determinants in various combinations. Moreover, we provide the first reported co-existence of bla KPC-2 and bla IMP-26. Co-existence of multiple resistance genes in CRE isolates contributes to MDR and poses formidable challenges for the treatment of clinically significant infections caused by these organisms. Effective surveillance and strict infection control strategies should be implemented to prevent nosocomial infections caused by these MDR pathogens in China.

ACKNOWLEDGEMENTS

This study was supported by grants from Wenzhou Municipal Science and Technology Bureau, China (Y20110043 and Y20100096) and Department of Education of Zhejiang province (Y201223071).

DECLARATION OF INTEREST

None.

References

REFERENCES

1. Tzouvelekis, LS, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clinical Microbiology Reviews 2012; 25: 682–707.CrossRefGoogle ScholarPubMed
2. Rapp, RP, et al. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy 2012; 32: 399–407.CrossRefGoogle ScholarPubMed
3. Maltezou, HC. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? International Journal of Antimicrobial Agents 2009; 33: 405 e401–407.CrossRefGoogle ScholarPubMed
4. Yong, D, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy 2009; 53: 5046–5054.CrossRefGoogle Scholar
5. Kumarasamy, KK, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infectious Diseases 2010; 10: 597–602.CrossRefGoogle Scholar
6. Leski, T, et al. Multidrug resistance determinants from NDM-1-producing Klebsiella pneumoniae in the USA. International Journal of Antimicrobial Agents 2012; 40: 282–284.CrossRefGoogle ScholarPubMed
7. Rimrang, B, et al. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. Journal of Antimicrobial Chemotherapy 2012; 67: 2626–2630.CrossRefGoogle ScholarPubMed
8. Bonnin, RA, et al. Dissemination of New Delhi metallo-beta-lactamase-1-producing Acinetobacter baumannii in Europe. Clinical Microbiology and Infection 2012; 18: E362–365.CrossRefGoogle Scholar
9. Shahcheraghi, F, et al. First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran. Microbiology Drug Resistance 2013; 19: 30–36.CrossRefGoogle Scholar
10. Chen, Y, et al. Emergence of NDM-1-producing Acinetobacter baumannii in China. Journal of Antimicrobial Chemotherapy 2011; 66: 1255–1259.CrossRefGoogle ScholarPubMed
11. Fu, Y, et al. Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. Journal of Antimicrobial Chemotherapy 2012; 67: 2114–2122.CrossRefGoogle ScholarPubMed
12. Zhou, Z, et al. Identification of New Delhi metallo-beta-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China. Canadian Journal of Microbiology 2012; 58: 112–115.CrossRefGoogle ScholarPubMed
13. Hu, H, et al. Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii . Antimicrobial Agents and Chemotherapy 2012; 56: 1698–1702.CrossRefGoogle ScholarPubMed
14. Hu, L, et al. Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China. Diagnostic Microbiology and Infectious Diseases 2013; 75: 373–376.CrossRefGoogle ScholarPubMed
15. Dortet, L, et al. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in the Sultanate of Oman. Clinical Microbiology and Infection 2012; 18: E144–148.CrossRefGoogle Scholar
16. Kumarasamy, K, et al. Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. Journal of Antimicrobial Chemotherapy 2012; 67: 243–244.CrossRefGoogle ScholarPubMed
17. Karthikeyan, K, et al. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. Journal of Antimicrobial Chemotherapy 2010; 65: 2253–2254.CrossRefGoogle ScholarPubMed
18. Wei, Z, et al. Coexistence of plasmid-mediated KPC-2 and IMP-4 carbapenemases in isolates of Klebsiella pneumoniae from China. Journal of Antimicrobial Chemotherapy 2011; 66: 2670–2671.CrossRefGoogle ScholarPubMed
19. Zhang, R, et al. Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. Journal of Medical Microbiology 2011; 60: 977–982.CrossRefGoogle Scholar
20. Islam, MA, et al. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. European journal of Clinical Microbiology and Infectious Diseases 2012; 31: 2593–2600.CrossRefGoogle ScholarPubMed
21. CLSI. Performance standards for antimicrobial susceptibility testing, 21th informational supplement (M100-S21). Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2011.Google Scholar
22. Poirel, L, et al. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrobial Agents and Chemotherapy 2011; 55: 934–936.CrossRefGoogle ScholarPubMed
23. Queenan, AM, et al. Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Review 2007; 20: 440–458.CrossRefGoogle ScholarPubMed
24. Yu, Y, et al. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. Jouranl of Infection 2007; 54: 53–57.CrossRefGoogle ScholarPubMed
25. Hu, F, et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. Journal of Medical Microbiology 2012; 61: 132–136.CrossRefGoogle ScholarPubMed
26. Chen, S, et al. High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrobial Agents and Chemotherapy 2011; 55: 2493–2494.CrossRefGoogle Scholar
27. Dai, W, et al. Characterization of carbapenemases, extended spectrum beta-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing. Infection, Genetics and Evolution 2013; 14: 1–7.CrossRefGoogle Scholar
28. Girlich, D, et al. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. Journal of Clinical Microbiology 2012; 50: 477–479.CrossRefGoogle ScholarPubMed
29. Castanheira, M, et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrobial Agents and Chemotherapy 2011; 55: 1274–1278.CrossRefGoogle ScholarPubMed
30. Wang, Y, et al. Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla KPC-2 and bla IMP-4. European journal of Clinical Microbiology and Infectious Diseases 2012; 31: 1867–1872.CrossRefGoogle ScholarPubMed
31. Li, B, et al. First report of Klebsiella oxytoca strain coproducing KPC-2 and IMP-8 carbapenemases. Antimicrobial Agents and Chemotherapy 2011; 55: 2937–2941.CrossRefGoogle ScholarPubMed
32. Jiang, Y, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. Journal of Antimicrobial Chemotherapy 2008; 61: 1003–1006.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Dendrogram of patterns for carbapenem-resistant K. pneumonia isolates obtained by pulsed-field gel electrophoresis.